Skip to main content
Equibles

Cornerstone Planning Group LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1822587 FAIRFIELD, NJ
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$29,199
-$3,888 QoQ
Shares Held
97
-3.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#649
of 786 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cornerstone Planning Group LLC holds $333,862 across 45 Biotechnology names. ALNY ranks #4 (8.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 130 $64,574
2 RVMD
Revolution Medicines, Inc.
 199 $37,268
3 HALO
Halozyme Therapeutics, Inc.
 389 $30,447
4 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		97 $29,199
5 RPRX
Royalty Pharma plc
 373 $20,914
6 CRSP
CRISPR Therapeutics AG
 300 $16,362
7 ARGX
Argenx SE
 17 $15,772
8 ABCL
AbCellera Biologics Inc.
 2,000 $15,700

All Filings in ALNY

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $29,199 97
2026-03-31 $33,087 100
2025-12-31 $37,776 95
2025-09-30 $224,352 492
2025-06-30 $13,695 42
2025-03-31 $9,180 34
2024-12-31 $5,412 23
2024-09-30 $6,325 23
2024-06-30 $3,159 13
2023-12-31 $191 1
2023-09-30 $177 1